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1. Introduction      
In mammalians, heart rhythm originates in the sinoatrial node, a specialized region of the 
right atrium with defined anatomical and functional properties. The sinoatrial node acts as 
primary pacemaker in the heart owing to its unique ability to generate spontaneous action 
potentials at a rate faster than subsidiary pacemakers (the atrioventricular node and 
Purkinje fibers) (Vassalle, 1977).  Propagation of action potentials from the sinoatrial node is 
first directed to the atria and then to the ventricles through a specialized conduction system 
that drives and coordinates the rhythmic contraction of heart chambers (Figure 1).  
The pacemaker function of the sinoatrial node derives from a key electrogenic property, the 
diastolic depolarization phase or pacemaker phase of the action potential. It is a slow, 
positive increase in voltage across the cell membrane occurring between the end of one 
action potential and the beginning of the next; it causes the cell membrane to reach the 
threshold potential required to generate a subsequent action potential (DiFrancesco, 1991; 
DiFrancesco, 2010). The diastolic depolarization phase is absent in normal atrial and 
ventricular myocytes that rest at stable membrane potential values at the termination of the 
action potential.  
Investigations aimed at elucidating the ionic mechanisms of pacemaking have proposed 
different candidates as major contributors responsible for the generation of the diastolic 
depolarization phase. At present, despite the issue is still a matter of debate, a wealth of 
information clearly agrees that two major mechanisms, membrane-associated ion currents 
and calcium release from sarcoplasmic reticulum, contribute to form a coordinated system 
that drives automaticity of normal cardiac pacemaker cells (Lakatta et al., 2010).  
Among the membrane associated currents, the hyperpolarization-activated current or funny 
current (If ) is considered a major player in both generation of cardiac spontaneous activity 
and rate control (DiFrancesco, 1991; DiFrancesco, 2010). If is an inward mixed-cation current 
carried by potassium and sodium, slowly activating on hyperpolarization at voltages 
comprising the diastolic depolarization phase of sinoatrial node cells (−40/−60 mV); for 
these reasons it was termed funny current. Accordingly, several loss-of-function mutations 
(DiFrancesco, 2010), as well as the down-regulation of constitutive subunits of f-channel in 
pacemaker cells (Zicha et al., 2005) have been demonstrated to cause sinus node dysfunction 
and rhythm disturbances.  
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Representative action potentials from different regions of the heart. Displacement in time reflects the 
temporal sequence of impulse propagation through the heart. Abbreviations: SAN,  sinoatrial node; A, 
atrium; AVN, atrioventricular node; PF, Purkinje fibers; V, ventricle; ms, milliseconds. 
Fig. 1. Action potential profiles and propagation in the human heart.  
Despite funny current expression has long been considered restricted to the sinus node and 
other regions of the conducting system, i.e. those cells possessing a diastolic depolarization 
phase, functional and molecular data collected over the last fifteen years have identified 
funny channels in non-pacemaker cardiomyocytes of the heart, namely in atrial and 
ventricular myocytes (Cerbai & Mugelli, 2006; Biel et al., 2009). In this cells, the increased 
expression of funny current occurring in cardiac diseases (see below), such as in 
hypertrophy and failure, has been suggested to contribute to ectopic beat formation and 
enhanced electrical activity. 
2. Molecular properties and distribution of funny channels in the normal 
heart    
Funny channel constitutive subunits were cloned starting from the late 1990s (Ludwig et al., 
1999; Moosmang et al., 2001; Biel et al., 2009). They belong to the superfamily of the voltage-
dependent potassium and cyclic nucleotide regulated channels and represent a gene family 
comprising four members, termed Hyperpolarization-activated Cyclic Nucleotide-gated 
(HCN1-4) channels.  
The four different subunits assemble in homo-tetramers with distinct biophysical properties, 
but there is evidence in vivo that different subunits may combine in the same protein 
complex forming hetero-tetramers with specific kinetic and modulatory properties (Figure 
2) (Biel et al., 2009). HCN isoforms share a highly conserved transmembrane core sequence, 
while their N and C termini vary considerably in terms of length and sequence homology. 
www.intechopen.com
The Funny Current in Cardiac Non-Pacemaker Cells: Functional Role 
and Pharmacological Modulation   
 
597 
In the membrane, HCN tetramers form pore-loop channels that arrange around a centrally 
located pore. Each subunit consists of six α-helical transmembrane segments that include 
the core sequence, responsible for channel gating properties and ion selectivity, and the 
intracellular cytosolic C-terminal domain, responsible for channel modulation by cyclic 
nucleotides.  
In the adult heart, a wealth of information documented a robust expression of HCN1, HCN2 
and HCN4 isoforms, while very low levels of HCN3 are present (Cerbai & Mugelli, 2006; 
Biel et al., 2009). In general, there is a strong variation of isoform quantity according to 
cardiac region, since expression levels of total HCN channels are low in normal atrial and 
ventricular muscle compared with those detected in the sinoatrial node region and in the 
conduction system. Moreover, there is also a clear variation of isoform predominance 
according to species. In the adult sinoatrial node of humans, rabbit, guinea pig, mouse and 
dog, HCN4 is the dominant isoform, accounting for the majority of the total HCN 
transcripts. By contrast HCN2 isoform predominates in rat sinoatrial node. The remaining 
fraction is mainly represented by HCN2 isoform in humans and mouse and HCN1 isoform  
 
 
A: Representative family of If traces elicited by hyperpolarizing steps recorded in a sinoatrial node cell 
isolated from guinea-pig. B: Tetrameric structure of HCN channels: each monomer is formed by six 
trans-membrane segments (1-6), a pore loop (P) between segments 5 and 6, a voltage sensor motif in 
segment 4 and a cyclic-nucleotide-binding domain (CNBD) in the C-terminal region; C: HCN family 
formed by four isoforms termed HCN1-4. D: HCN isoform distribution in different regions of the 
human heart; intensity of colour is an index of isoform expression. Abbreviations: nA, nanoAmpere; 
ms, milliseconds; SAN,  sinoatrial node; A, atrium; AVN, atrioventricular node; PF, Purkinje fibers; V, 
ventricle. 
Fig. 2. Properties, topology and distribution of funny-channels in the heart. 
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in rabbit. HCN4 is the most abundant isoform in human atrioventricular node and Purkinje 
fibers, while HCN2 is the most largely expressed isoform in canine Purkinje fibers. Rabbit 
Purkinje fibers exhibit little If which is associated to low levels of HCN4 and HCN1 
expressed in equal amount. In the conduction system no expression or only very low 
expression levels have been reported for HCN3 isoform. Despite the high interspecies 
variability shown by funny channels in the heart, a number of data point to HCN4 and 
HCN2 as the most represented isoforms in  atrial and ventricular muscle of the majority of 
mammals, including humans. In these regions low levels of HCN1 and HCN3 have also 
been detected.   
3. Expression and properties of funny channels in ventricular 
cardiomyocytes 
The study of the electrophysiological mechanisms of arrhythmias has characterized the 
activity of our research group since long time (Vassalle & Mugelli, 1981).  In the early 1990s, 
we were actively studying the electrophysiological alterations occurring in the 
hypertrophied heart of old spontaneously hypertensive rats. The goal was to get insight into 
the electrophysiological mechanisms underlying the enhanced arrhythmogenesis occurring 
in cardiac hypertrophy. We found that action potentials recorded in left ventricular 
papillary muscles isolated from hypertrophied hearts showed several electrophysiological 
alterations including an unusual diastolic depolarization phase, which was not present in 
preparations excised from normal hearts (Barbieri et al., 1994). Interestingly enough, in the 
same experimental model we documented that the slope of this sort of diastolic 
depolarization was clearly enhanced upon catecholamine stimulation, similarly to what 
previously described for the oscillatory current in Purkinje fibers (Vassalle & Mugelli, 1981). 
We were able to demonstrate that a relevant contribution to the diastolic depolarization 
phase present in hypertrophied hearts was due to the occurrence of an atypical If current 
that was functionally expressed in ventricular hypertrophic cardiomyoctes, but not in 
normal cardiomyoctes (Cerbai et al., 1994). Later on we demonstrated that If density in the 
hypertrophied rat hearts was linearly related to the severity of myocardial hypertrophy 
(Cerbai et al., 1996).  
If recorded in ventricular rat cardiomyocytes showed electrophysiological properties, 
responsiveness to autonomic transmitters and sensitivity to pharmacological blockade 
similar to those observed for If expressed in the sinoatrial node (Cerbai et al., 1996). In 
particular, voltage-dependence, kinetics of activation and ionic selectivity were qualitatively 
similar to those retrieved in cardiac pacemaker cells. However, threshold of current 
activation differed substantially, being much more negative (about -70 mV) than that 
reported for sinoatrial node cells (-40 mV). On the basis of present knowledge on diverse 
HCN isoform distribution in the heart (see previous paragraph), the observed difference on 
If current activation likely reflects a diverse composition of HCN isoforms contributing to 
channel complex in the sinoatrial node and in the ventricular tissue. In addition to this, 
membrane sub-localization with interacting proteins, e.g. caveolin-3, may also contribute to 
differences  in channel voltage activation (Barbuti et al., 2004; Barbuti et al., 2007). Despite 
the observed properties of funny current in the ventricular cardiomyocytes, a contribution 
to the diastolic phase of ventricular action potential is possible, since membrane resting 
potential is also more negative in ventricular cells than in sinoatrial node cells.  
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Action of catecholamines on the funny current expressed in ventricular myocytes was 
proved to closely resemble that reported for  myocytes from sinoatrial node (Cerbai et al., 
1999). In fact, stimulation of β-adrenoceptors shifts the If activation curve toward less 
negative values, with no change in the amplitude of the maximal specific conductance of the 
current. According to early observations (DiFrancesco & Tortora, 1991; DiFrancesco, 2010), 
this effect results from a direct binding and positive modulation of channel function exerted 
by 3'-5'-cyclic adenosine monophosphate nucleotide, whose intracellular levels are greatly 
enhanced by β-adrenoceptors stimulation. The effect of catecholamines on the funny current 
expressed in ventricular myocytes is in accordance with the diverse sensitivity to cyclic 
nucleotide reported for the different channel isoforms. Indeed, HCN2 and HCN4, the most 
abundant isoforms in the ventricle, are largely modulated by cyclic nucleotides, while 
HCN1 and HCN3, which are not present or have a very low expression in the ventricle, are 
weakly affected (Biel et al., 2009). 
Subsequent experimental evidence led to the demonstration that If over-expression in 
ventricular cells occurred in other models of cardiac hypertrophy (Stilli et al., 2001) or 
following myocardial infarction (Sartiani et al., 2006): this suggests the involvement of a 
common mechanism controlling funny channels expression in cardiac diseases, such as 
ischemia and pathological hypertrophy. Finally and most importantly, a similar If gain-of-
function was reported in human cardiac ventricular myocytes isolated from explanted  
 
 
Columns represent the ratio between current density measured in ventricular myocytes from diseased 
hearts, and respective control; bars are confidence intervals (95%). In newborn rats, values measured at 
2 weeks are compared to those at 2 days after birth. LVH-mild, LVH-severe: relative increase of If 
current in rats with mild or severe left ventricular hypertrophy caused by aortic banding or long-lasting 
pressure overload, respectively. PO-HF, PMI-HF: relative increase of If in rats with overt heart failure, 
resulting from uncompensated hypertrophy due to pressure-overload or following a myocardial 
infarction due to coronary ligation, respectively. DCM, ICM: relative increase of If in patients 
undergoing cardiac transplantation for terminal dilated or ischemic cardiomyopathy, respectively. For 
all conditions, the relative increase of If density was statistically significant versus controls, that is, 
normotensive rats, sham-operated rats, or normal donor hearts not transplanted for technical reasons, 
with the exception of DCM patients. 
Fig. 3. If over-expression in cardiomyophaties and during cardiac development. 
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hearts (Cerbai, 1997; Hoppe, 1998). Interestingly enough, in human ventricular myocytes 
functional over-expression of If appeared to be related to the etiology of the disease, since 
current density is higher in ischemic than in dilated cardiomyopathy (Figure 3) (Cerbai et 
al., 2001).  
Overall, these observations suggested that in the setting of structural and functional 
myocardial remodeling induced by pathology, If gain-of-function may contribute to the 
increased propensity for arrhythmias, a phenomenon documented both in patients and in 
experimental animal models. In this context, an over-activation of adrenergic system may 
increase the arrhythmogenic role played by If channels.  
In the human healthy ventricle, distribution of HCN isoforms shows a robust expression of 
HCN2 and HCN4 isoforms. In accordance with the electrophysiological data showing a 
larger amplitude of funny current in failing human ventricular myocytes, levels of HCN4 
and HCN2 isoforms are greatly enhanced both at transcriptional (Figure 4) and protein 
 
 
Representative traces of If recorded in a normal (A) and a hypertrophic (B) ventricular cardiomyocyte 
(VCM) isolated from human hearts. C: Quantification of HCN2 and HCN4 mRNA relative to the 
reference gene Glyceraldehyde-3-Phosphate Dehydrogenase,  in human normal and hypertrophic 
ventricle (Normal V and Hypertrophic V, respectively). Abbreviations: pA, picoAmpere; pF, picoFarad;  
mV, milliVolts; ms, milliseconds. 
Fig. 4. Functional and molecular properties of funny-channel in the human ventricle. 
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levels (Stillitano et al., 2008). A similar increase of HCN4 and HCN2 has been also 
documented in animal models of cardiac infarction (Suffredini et al., 2009) and hypertrophy 
(Fernandez-Velasco et al., 2003) and strongly suggests that cardiac pathology affects funny 
channel expression in ventricular myocytes. This phenomenon could modify the 
electrophysiological properties of cardiomyocytes, raising the tendency of the ventricular 
muscle to develop ectopic action potentials. 
In summary, funny channel over-expression in non pacemaker ventricular cells, is a marker 
of remodeling induced by pathology and is likely to predispose cells to electrical instability. 
Funny channel over-expression, if associated with particular conditions documented in 
heart failure -namely a reduced expression of inwardly rectifying potassium current and 
elevated β-adrenergic stimulation- might contribute to trigger fatal arrhythmias. 
3. Expression and properties of funny channels in atrial cardiomyocytes 
Existence of funny current in human atrial appendage fibers was documented by Carmeliet 
on 1984 (Carmeliet, 1984), who first hypothesized the inherent potentiality of this current in 
human atrial tissue to develop spontaneous activity. The following experimental evidence 
allowed a thorough description of the properties of the funny current expressed in isolated 
human atrial myocytes obtained from atrial appendages excised during corrective 
cardiosurgery (Heidbuchel et al., 1987; Thuringer et al., 1992; Porciatti et al., 1997). On the 
basis of a number of experimental data it was documented that the funny current in atrial 
myocytes has a large variability in terms of amplitude and shows an activation voltage more 
negative than the atrial diastolic potential. These observations led to the general conclusion 
that the contribution of funny current to atrial electrogenesis is likely to be negligible in 
normal conditions. Despite this, a clear-cut diastolic depolarization phase is observed in 
human atrial myocytes, provided that integrity of the intracellular milieu is preserved using 
the perforated patch technique (Cerbai & Mugelli, 2006).  
The physiological role of funny current in normal atrial tissue is still a matter of 
investigation; however, a contribution to atrial electrogenesis has been suggested in 
pathological conditions and/or following the activation of specific neurohumoral signals 
that may amplify current density at physiological potentials (Opthof, 1998; Michels et al., 
2005). Among the potentially relevant signals, two are peculiar of the human atrium and 
have been investigated in our laboratory: serotonin and atrial natriuretic peptide. Serotonin 
subtype-4 receptors are typically expressed in the human atrium (Kaumann, 1991), where at 
least four different splicing-variant isoforms have been identified (Blondel et al., 1998; Bach 
et al., 2001; Lezoualc’h et al., 2007). Serotonin subtype-4 receptors are coupled to Gs proteins 
that upon stimulation increase intracellular levels of 3'-5'-cyclic adenosine monophosphate 
(Pindon et al., 2002) that positively modulates the funny current. Atrial natriuretic peptide is 
synthesized and stored as pro-hormone in granules localized in human atrial myocytes 
(Venugopal, 2001). Upon atrial distension, the peptide is released and interacts with specific 
receptors, namely natriuretic peptides receptor A and B. These are membrane-associated 
receptors coupled to guanylyl cyclase activity that increases intracellular 3'-5'-cyclic 
guanosine monophosphate nucleotide, which similarly to the adenosine cyclic nucleotide, 
binds to funny channels and increases the current. Accordingly, both serotonin and atrial 
natriuretic peptide proved to increase If current in human atrial myocytes (Pino et al., 1998; 
Lonardo et al., 2004). The effect is concentration-dependent and shows an affinity constant 
(Kd) quite similar to the physiological concentrations of serotonin and atrial natriuretic 
peptide likely reached upon adequate stimuli, i.e. local release during platelet aggregation 
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or cell stretching, respectively. On the whole, these findings suggest that stimuli most likely 
involved in atrial arrhythmias are able to cause a gain of function of funny current in human 
atrial myocytes. Again this phenomenon could influence cell excitability and predispose to 
the occurrence of atrial arrhythmias.  
4. Funny channel over-expression in cardiomyocytes is a marker of 
regression toward an immature phenotype 
The understanding of the mechanisms and factors responsible for the functional over-
expression of funny current in cardiac diseases is of great importance. Cardiac remodeling is  
a well defined phenomenon consisting of modifications in the structural and functional 
properties of the cardiac tissue (Swynghedauw, 1999), which occurs in several cardiac 
diseases. We hypothesized that the over-expression of funny channels in the diseased 
ventricle is likely part of the fetal/embryonic gene pattern that is known to be re-expressed 
in the heart during remodeling.  
Ventricular cardiomyocytes are physiologically quiescent in the adult stage, but their action 
potentials exhibit a clear-cut diastolic depolarization phase in the immature stage. This 
property was associated with a robust expression of funny current in both rat fetal and 
neonatal cardiomyotes (Cerbai et al., 1999; Robinson et al., 1997; Sartiani et al., 2010). Further 
experimental evidences demonstrated that funny current occurrence and density are 
maximal in the first week of post-natal life and progressively decrease during maturation, 
reaching a low steady-state levels at one month of age. A minority of myocytes isolated from 
the hearts of adult rats express If, which, when present, was of small amplitude.  
In accordance with data reported in the fetal mouse (Yasui et al., 2001; Mommersteeg et al., 
2007; Schweizer et al., 2009), expression analysis in the rat documented that both HCN4 and 
HCN2 isoforms account for the majority of total HCN transcript in the neonatal ventricle, 
while HCN1 and HCN3 isoforms are not expressed at detectable levels (Sartiani et al., 2010). 
Interestingly, HCN4 is down-regulated during rat heart maturation, but in association with 
HCN2 it undergoes a clear-cut up-regulation after cardiac infarction (Suffredini et al., 2009). 
This observation confirms the hypothesis that transcriptional regulation in the remodeled 
heart involves funny channel isoforms typical of the immature ventricle, which are 
modulated as part of a panel of other key fetal/immature genes.   
At variance with experimental animal models, obvious difficulties are encountered to get 
information on developmental changes of funny current in humans. A useful experimental 
model to overcome this difficulty is represented by human embryonic stem cells induced to 
differentiate toward the cardiac phenotype (Sartiani et al., 2007; Bettiol et al., 2007). This 
model is reported to recapitulate native cardiac embryogenesis and maturation, thus 
representing a useful tool to study early human cardiac development and growth. Using 
this model we documented that the funny current is present since the undifferentiated state, 
where its functional role in association with other ion channels, e.g. delayed rectifier 
potassium channels, still remains to be elucidated. After induction of cardiac differentiation, 
funny channels continue to be functionally present both in the early and late stages of 
cardiac differentiation. During this process the differentiating human cardiomyocytes 
undergo a number of key changes in terms of excitable properties and molecular phenotype 
that include modifications of funny channels. In fact, kinetics of If activation are markedly 
slowed-down in late-stage cardiomyocytes compared to the early ones and undifferentiated 
cells. Changes in kinetics during differentiation and maturation turned out to result from 
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modifications of isoforms contributing to channel complex. In fact, when heterologously re-
expressed as homomeric channels, HCN1 shows rapid activation kinetics (tens of 
milliseconds), whereas HCN2 and HCN4 activate in hundreds of milliseconds. In 
accordance with functional data, expression analysis of HCN isoform on differentiating 
cardiomyocytes showed that HCN1 isoform, which has the fastest activation kinetics, is 
largely expressed in undifferentiated cells and in early-stage cardiomyocytes, but is 
significantly reduced during maturation. The slower HCN2 isoform is expressed 
homogeneously throughout the differentiation process while HCN4 results to be 
dramatically down-regulated. On the whole, these observations suggest that, in accordance 
with data retrieved in native cardiac tissue (Figure 4), in human cardiomyocytes 
differentiated from embryonic stem cells HCN2 and HCN4 account for the majority of total 
HCN transcript and likely contribute to funny channel complex and properties.  
In conclusion, funny channels are abundantly expressed in human cardiomyocytes 
differentiated from embryonic stem cells at all stages of differentiation and thus they 
represent a marker of immature cardiac phenotype in mammals. During maturation funny 
channels undergo modifications in terms of current properties and isoform composition.  As 
previously suggested for the rat heart, changes in HCN isoform expression (down-
regulation of HCN4) are opposite to those observed in heart hypertrophy and failure (up-
regulation of HCN4 and HCN2) where the functional re-expression of funny current likely 
represent a regression toward an immature cardiac phenotype. 
5. Pharmacological modulation of funny channels in the heart 
In heart hypertrophy and failure, a complex signaling network contributes to initiate and 
exacerbate cardiac functional and molecular remodeling. Over the last years, a growing 
number of experimental evidence has been accumulating and documented the involvement 
of diverse factors in the patophysiology of the phenomenon. To date only some signalling 
pathways have been identified and extensively studied. Among the best documented, 
experimental and clinical evidence points to a central role for the increased levels of 
systemic and locally released hormonal factors, including norepinephrine, angiotensin II, 
endothelin I, aldosterone and cytokines (De Mello, 2004; Swynghedauw, 1999). 
On the basis of our observation that funny channels are over-expressed in the diseased 
ventricular tissue, we assessed the involvement of the renin-angiotensin system, that is 
activated in cardiac hypertrophy/failure, in the regulation of funny channels (Figure 5). 
Using an experimental model of cardiac hypertrophy, the old spontaneously hypertensive 
rat, we tested the effect of type-1 angiotensin II receptor antagonists, losartan or irbesartan, 
orally administered for 8-weeks. The treatment proved to prevent the development of 
several  electrophysiological alterations associated with cardiac hypertrophy, i.e. the action 
potential prolongation, the transient outward potassium current down-regulation and also 
the over-expression of funny current (Cerbai et al., 2000; Cerbai et al., 2003). 
Recent clinical trials documented that reduction of heart rate with pacing (Rao et al., 2007) or 
selective bradycardic agents (Swedberg et al., 2010; Böhm et al., 2010) is associated to 
improved clinical outcomes in heart failure. Studies were performed in animal models to 
assess whether selective pharmacological intervention able to control heart rate were able to 
revert and/or ameliorate functional remodeling of ventricular tissue in cardiac diseases. In a 
rat model of myocardial infarction it was documented that reduction of heart rate with a  
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Abbreviations: AT1 R: angiotensin II receptor type 1. 
Fig. 5. Schematic representation of pharmacological interventions able to modulate funny 
channel expression and/or function in cardiomyocytes. 
selective bradycardic agent (ivabradine, see below for further details) is able to improve 
maximal myocardial perfusion and coronary reserve (Dedkov et al., 2007). On the basis of 
this evidence, we tested whether heart rate reduction with ivabradine in post-infarcted rats 
could counteract the electrophysiological remodeling of ventricular myocytes. Preliminary 
results proved that the treatment was able to ameliorate cardiac function as well as ion 
channels alterations, in particular the down-regulation of transient outward potassium 
current and the over-expression funny channels occurring in post-infarcted animals 
(Suffredini et al., 2009; Ceconi et al., 2007). At present, the mechanism(s) responsible for the 
reduction/reversion of ventricular functional remodeling with heart rate slowing drugs 
remains unknown and further investigations are necessary.   
On the whole, over-expression of funny channels in ventricular cardiomyocytes is promoted 
by hypertrophic factors whose levels are increased during cardiac hypertrophy and failure. 
Over-expression of funny channels is inhibited by drugs that revert or prevent many of the 
electrophysiological alterations described in the remodeled cardiac myocytes. 
In the last years, we have explored the pharmacological strategy aimed to modulate directly 
the cardiac funny channels, identifying novel molecules that act as direct channel blockers. 
The interest in funny channels direct modulators has emerged due to the approval of 
ivabradine (a prototype blocker of funny channel with selective bradycardic properties) for 
the treatment of stable angina pectoris. Our experimental approach took advantage of 
classical medicinal chemistry and electrophysiology and aimed to identify novel derivatives, 
structurally related to zatebradine (Romanelli et al., 2005), a different prototype blocker of 
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funny channels, whose clinical trials were stopped due to adverse side effects. Moreover, 
since the most serious side effects of zatebradine are due to unselective blockade of the HCN 
isoforms present in tissues different from the heart, i.e. retinal rods and nervous system, one 
additional aim was to develop compounds able to discriminate among the HCN channel 
isoforms. Our recent results (Melchiorre et al., 2010) have uncovered diverse structural 
requirements necessary to provide derivative selectivity for the diverse HCN isoforms, 
which suggest a potential interest of these compounds as novel selective bradycardic agents. 
Investigations are currently characterizing the pharmacological profile of these novel funny 
channel blockers especially looking at their isoform selectivity.  
6. Summary and conclusion 
After their first discovery in the sinoatrial node, funny channels have been identified as key 
physiological regulators of pacemaker function in the heart. Subsequent studies have 
documented their expression in the atrial and ventricular muscles, where diverse pathologic 
conditions, such as cardiac hypertrophy and failure, cause their functional enhancement. 
This observation and the identification of different signaling pathways able to promote their 
function in the atria and ventricles has led to the suggestion that the funny current in non 
pacemaker cardiomyocytes may influence membrane excitability and predispose to the 
occurrence of arrhythmias. However, this hypothesis remains unproved in both 
experimental and clinical settings. The recent SHIFT study (Swedberg et al., 2010; Böhm et 
al., 2010) showed that ivabradine improves clinical outcomes in chronic heart failure, 
pointing to the reduction of heart rate as fundamental mechanism of drug action. However, 
the accompanying editorial (Teerlink, 2010) hypothesized that other mechanisms such us 
blockade of funny channels in the ventricle may contribute to the beneficial effects of 
ivabradine. Despite the progresses made, numerous key questions still remains unanswered 
and deserve a thorough investigation in the future. Among the most important, some of the 
unknown issues relate to: 
i. the relevance and the specific role of funny channels in non pacemaker cells in different 
cardiac diseases.  
1. the factors and signalling pathways controlling the expression, the cellular processing, 
and the sub-cellular compartmentation of funny channels in the normal and diseased 
heart.  
2. the identifications of proteins and/or other (bio)molecules able to interact and 
modulate funny channels function in physiological and pathological conditions.  
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